BioWorld

July 27, 2015

Early immunotherapy success in multiple myeloma

Multiple myeloma has joined the ranks of tumor types that show benefit from immunotherapy treatment, with early stage clinical results reported in the July 20, 2015, issue of Nature Medicine. Read More

Week in review

Word on the street

Week in Washington

American diabetes association’s scientific sessions: June 2015

American society of clinical oncology: June 2015

European hematology association: June 2015

Pharma clinical and FDA action update: June 2015

Money raised by biotech in 2015 vs. 2014

Money raised by biotech: Jan. 1 - July 23, 2015

The week's biggest gainers and losers

BioWorld stock report for public biotechnology companies

Today's news in brief

BioWorld

BioWorld briefs for Feb. 5, 2025.

Today's news in brief

Briefs

BioWorld MedTech briefs for Jan. 30, 2026.

MicroRNAs in circulating extracellular vesicles as IPF biomarkers

BioWorld Science

MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...

REST emerges as biomarker in ALS, knockdown improves ALS symptoms

BioWorld Science

About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...